Literature DB >> 22858568

Central diabetes insipidus: an unusual complication in a child with juvenile myelomonocytic leukemia and monosomy 7.

Pacharapan Surapolchai1, Shau-Yin Ha, Godfrey Chi-Fung Chan, Johannes B Lukito, Thomas S K Wan, Chi-Chiu So, Alan Kwok-Shing Chiang.   

Abstract

Central diabetes insipidus (DI) is well-documented as a presenting feature of myelodysplastic syndrome and acute myeloid leukemia in adults. However, DI is unusual in pediatric patients with myeloid malignancies. We report here this rare complication in a child with neurofibromatosis type 1 who developed juvenile myelomonocytic leukemia and monosomy 7. Our case and previously reported cases of DI arising as a complication in myeloid malignancies demonstrate a close association with deletion of chromosome 7. The clinical characteristics and outcomes of these uncommon cases in children are reviewed and discussed.

Entities:  

Mesh:

Year:  2013        PMID: 22858568     DOI: 10.1097/MPH.0b013e3182580d88

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  'If there were water we should stop and drink': neurofibromatosis presenting with diabetes insipidus.

Authors:  Rachel Barry; Antoinette O' Connor; Mohn Hazriq Awang; Orna O' Toole
Journal:  BMJ Case Rep       Date:  2018-02-11

2.  Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia.

Authors:  John C Molina; Julie M Asare; Laura Tuschong; Robert R West; Katherine R Calvo; Rebecca Persky; Alison M Boyce; Dima A Hammoud; Steven M Holland; Dennis Hickstein; Nirali N Shah
Journal:  Pediatr Blood Cancer       Date:  2020-12-27       Impact factor: 3.838

Review 3.  Cancer cytogenetics: methodology revisited.

Authors:  Thomas S K Wan
Journal:  Ann Lab Med       Date:  2014-10-28       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.